Veradigm | MDRX - Despesas De Vendas E Administração

Preço das Ações
4.21
Mudança Diária
-0.10 -2.32%
Mensal
-9.46%
Anual
-0.94%
Q2 Previsão
4.12




Despesas De Vendas E Administração Alterar Data
Alcidion AUD 1.09M 184K 2025-12
Ambu A/S DKK 689M 50M 2025-12
Cardinal Health USD 1.5B 43M 2025-12
Centene USD 3.37B 236M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cigna USD 3.19B 242M 2025-09
Coloplast 2.64B 52M 2025-12
Computer Programs Systems USD 51.62M 109.74M 2025-12
Convatec Group USD 420.3M 210.35M 2024-12
Diasorin EUR 100.15M 18.26M 2025-09
Elevance Health USD 10.91B 309M 2025-12
General Electric Aerospace USD 1.58B 385M 2025-12
Gulf Medical Proj AED 915K 52K 2025-12
Humana USD 3.36B 614M 2025-03
IQVIA Holdings USD 468M 46M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Maximus USD 152.16M 35.52M 2025-12
McKesson USD 2.03B 44M 2025-12
Med Life RON 23.07M 3.23M 2025-09
Molina Healthcare USD 1.33B 98M 2025-12
Omnicell USD 107.36M 5.12M 2025-12
Oriola-kd EUR 13M 3.1M 2025-09
Owens Minor USD 258.98M 7.5M 2025-12
Quest Diagnostics USD 504M 3M 2025-12
Rede D'or Sao Luiz BRL 69.46M 513.18M 2025-12
Siemens Healthineers EUR 925M 50M 2025-12
Sonova Holding CHF 880.2M 300K 2025-06
UnitedHealth USD 15.22B 1.44B 2025-09
Veeva Systems USD 125.08M 3.11M 2025-12
Veradigm USD 27.28M 5.24M 2022-12
Xerox USD 368M 10M 2025-06